Ads
related to: eli lilly stock- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 6 days agoShares recently retook their 50-day line, MarketSurge analysis shows. The Next Big Driver For Teva ...
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To...
Benzinga· 2 hours agoPatients using Novo Nordisk’s NVO NONOF obesity treatment, Wegovy, have reportedly maintained an...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks· 6 days agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium ...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 7 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoBut, there are several bearish factors plaguing Pfizer stock. Revenue from its Covid products —...
Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
Barrons.com· 5 days ago“We are also looking for developing a therapeutic here which has durability…so that we can do...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks· 4 days agoFree Report) reported the death of a young boy who participated in a mid-stage study of its Duchenne muscular dystrophy (“DMD”) drug, fordadistrogene movaparvovec. An FDA advisory committee ...
Earnings-Proof Tech Plays: 3 Stocks Set to Stay Hot Beyond Reporting Season
InvestorPlace· 4 days agoDepending on where you look, there has been quite a tough crowd of investors to please this earnings...
This 1 Simple ETF Could Turn $100 a Month Into $93,200
Motley Fool via Yahoo Finance· 5 days agoYour invested dollars will have nearly quadrupled over the years, and you will never have to pick a...
Ad
related to: eli lilly stock